ATE281841T1 - Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen - Google Patents

Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen

Info

Publication number
ATE281841T1
ATE281841T1 AT00985359T AT00985359T ATE281841T1 AT E281841 T1 ATE281841 T1 AT E281841T1 AT 00985359 T AT00985359 T AT 00985359T AT 00985359 T AT00985359 T AT 00985359T AT E281841 T1 ATE281841 T1 AT E281841T1
Authority
AT
Austria
Prior art keywords
proliferative diseases
mikanolides
dihydromicanolides
mikania
producing
Prior art date
Application number
AT00985359T
Other languages
English (en)
Inventor
Beng Poon Teng
Gregoire Prevost
Pannetier Marie-Christi Brezak
Mohamed Moumen
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE281841T1 publication Critical patent/ATE281841T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
AT00985359T 1999-12-01 2000-11-30 Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen ATE281841T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9915126A FR2801792B1 (fr) 1999-12-01 1999-12-01 Un nouveau medicament, le dihydromikanolide, son obtention par extraction de la plante mikania micrantha et son utilisation comme agent anti-proliferatif
PCT/FR2000/003337 WO2001039720A2 (fr) 1999-12-01 2000-11-30 Inhibiteurs des adn polymerases, le mikanolide et le dihydromikanolide

Publications (1)

Publication Number Publication Date
ATE281841T1 true ATE281841T1 (de) 2004-11-15

Family

ID=9552757

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00985359T ATE281841T1 (de) 1999-12-01 2000-11-30 Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen

Country Status (13)

Country Link
US (2) US6767561B2 (de)
EP (1) EP1237562B1 (de)
JP (1) JP2003515546A (de)
AT (1) ATE281841T1 (de)
AU (1) AU2180501A (de)
CA (1) CA2393056A1 (de)
DE (1) DE60015791T2 (de)
DK (1) DK1237562T3 (de)
ES (1) ES2232515T3 (de)
FR (1) FR2801792B1 (de)
PT (1) PT1237562E (de)
RU (1) RU2254136C2 (de)
WO (1) WO2001039720A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202076B2 (en) * 2000-10-30 2007-04-10 Sru Biosystems, Inc. Label-free high-throughput optical technique for detecting biomolecular interactions
TWI293302B (en) 2001-01-12 2008-02-11 Sod Conseils Rech Applic New derivatives of mikanolide, their preparation and their therapeutic uses
FR2819513B1 (fr) * 2001-01-12 2005-06-17 Sod Conseils Rech Applic Nouveaux derives du mikanolide, leur preparation et leurs applications therapeutiques
FR2825278A1 (fr) * 2001-05-30 2002-12-06 Sod Conseils Rech Applic Produit comprenant du mikanolide, du dihydromikanolide ou un analogue de ceux-ci en association avec un autre agent anti-cancereux pour une utilisation therapeutique dans le traitement du cancer
EP1406895B1 (de) 2001-06-13 2008-08-27 Magnachem International Laboratories, Inc. Lactonformulierungen und verfahren zur anwendung
WO2004041217A2 (en) 2002-11-05 2004-05-21 Magnachem International Laboratories, Inc. Synthetic lactone formulations and method of use
WO2005102315A1 (en) 2004-04-23 2005-11-03 Magnachem International Laboratories, Inc. Synthetic lactone formulations for pain control
ATE538804T1 (de) * 2004-06-21 2012-01-15 Aveda Corp Auf lösungsmittel basierende pflanzenextrakte
FR2949343B1 (fr) * 2009-09-01 2011-10-21 Oreal Procede d'obtention d'un extrait vegetal, extrait vegetal obtenu selon le procede et composition cosmetique ou dermatologique contenant l'extrait
CN104082351A (zh) * 2014-06-03 2014-10-08 北京化工大学 以薇甘菊为载体的防蛀剂及其制备方法
CN104054754B (zh) * 2014-07-01 2016-08-31 广州中医药大学 一种薇甘菊蚊虫驱避剂
CN104322239B (zh) * 2014-08-29 2019-06-21 云南省林业科学院 一种利用麻竹控制薇甘菊的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07267940A (ja) * 1994-03-29 1995-10-17 Ajinomoto Co Inc 新規な１１員環化合物
US5773005A (en) * 1995-06-09 1998-06-30 Takahashi; Hidehiko Purified flavonoid and diterpene 5α-reductase inhibitors from thuja orientalis for androgen-related diseases

Also Published As

Publication number Publication date
JP2003515546A (ja) 2003-05-07
ES2232515T3 (es) 2005-06-01
US6767561B2 (en) 2004-07-27
PT1237562E (pt) 2005-03-31
US20050208155A1 (en) 2005-09-22
DE60015791D1 (de) 2004-12-16
EP1237562A2 (de) 2002-09-11
FR2801792B1 (fr) 2003-04-18
US20030118678A1 (en) 2003-06-26
DE60015791T2 (de) 2005-12-08
AU2180501A (en) 2001-06-12
EP1237562B1 (de) 2004-11-10
FR2801792A1 (fr) 2001-06-08
WO2001039720A3 (fr) 2002-04-04
CA2393056A1 (fr) 2001-06-07
WO2001039720A2 (fr) 2001-06-07
US7091239B2 (en) 2006-08-15
RU2254136C2 (ru) 2005-06-20
RU2002117303A (ru) 2004-02-27
DK1237562T3 (da) 2005-03-14

Similar Documents

Publication Publication Date Title
DE69523074D1 (de) Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung
DE60042611D1 (de) Verfahren zur behandlung von gefässerkrankungen, dxid auszeichnen
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE348808T1 (de) Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten
DE60031396D1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE69616376D1 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
EP1109548A4 (de) Zusammensetzungen und verfahren zur behandlung und vorbeugung von knochenkrankheiten unter verwendung von tocotrienole
DE60008753D1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
ATE260282T1 (de) Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE453402T1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
ATE251911T1 (de) Löslische hla-g enthaltende zusammensetsungen zur behandlung entzündlichen hautkrankheiten
DE69936994D1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
ATE262330T1 (de) Verwendung eines nitroxids oder seiner prodrugs zur prophylaktischen und therapeutischen behandlung von krebs
DE60206280D1 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
DE60023555D1 (de) Verfahren zur behandlung von gewebe
DE69820911D1 (de) Verwendung einer Verbindung zur Herstellung eines Medikaments zur Behandlung von Alopecia oder zur Förderung des Haarwuchses bei Tieren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1237562

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee